Delivery Order SPE2DB20D3101-SPE2DB25FRDB6

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,567.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of 4566649350 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, with a completion date of December 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $2,081.51, is for the delivery of 4564660449 FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period ending on May 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,737.96 firm fixed-price delivery order is for the supply of 4565904522 FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a critical care medication. The contract has an ultimate completion date of September 24, 2024 and was awarded on September 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a $1,664.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566681918 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DX15D3201|SPE2DX24F2R0M, is for the supply of 4563472588 units of the pharmaceutical product FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, without any set-aside designation. The contract has a ceiling value of $10,044.88 and an ultimate completion date of January 30, 2024. The prime contractor, Amerisourcebergen Drug Corp, is a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,335.54, is for the delivery of FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a medical product, with a completion date of December 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This contract award, valued at $1,360.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Fomepizole 1.5 GM/1.5 ML Vial 1.5ML, a critical medical commodity. The contract is a Firm Fixed Price Delivery Order with a completion date of February 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566945457 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a specialty pharmaceutical product. The contract has a ceiling value of $1,331.60 and an ultimate completion date of January 16, 2025. It is a Firm Fixed Price contract, with no set-aside designation. Amerisourcebergen holds a...
This contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of 4565020195 FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML, a critical pharmaceutical product. The $10,163.30 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a logistics and acquisition agency supporting the U.S. Department of Defense. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary...
This federal contract award (SPE2DB20D3505|SPE2DB21FU2W5) was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to serve as a prime vendor for pharmaceutical products and medical supplies. The contract, valued at $6,482.88, is a delivery order with a firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRDB6
    Delivery Order

This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FRDB6, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the supply of 4567409299 - FOMEPIZOLE 1.5 GM/1.5 ML VIAL 1.5ML. The award has a ceiling value of $7,225.89 and is a Firm Fixed Price Delivery Order contract, with a period of performance through February 28, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

This contract award does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:07 AM